Active ingredient
Verapamil
136 finished FDA listings contain Verapamil as their only active ingredient; 4 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- VERAPAMIL HYDROCHLORIDE
- Dosage forms
- Capsule, Delayed Release, Capsule, Delayed Release Pellets, Capsule, Extended Release, Injection, Injection, Solution, Tablet, Tablet, Extended Release, Tablet, Film Coated, Tablet, Film Coated, Extended Release
- Routes
- Intravenous, Oral
- Manufacturers / labelers
- 46
- Strengths listed
- 10 mg/4ml · 100 mg/1 · 120 mg/1 · 180 mg/1 · 2.5 mg/ml · 200 mg/1 · 240 mg/1 · 300 mg/1 · 360 mg/1 · 40 mg/1 · 5 mg/2ml · 80 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 11170
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 018925 | EXELA PHARMA | 1984-03-30 | 4 |
| ANDA 070994 | WATSON LABS | 1986-10-01 | 4 |
| ANDA 070995 | WATSON LABS | 1986-10-01 | 1 |
| ANDA 070738 | HOSPIRA | 1987-05-06 | 1 |
| ANDA 070737 | HOSPIRA | 1987-05-06 | 4 |
| ANDA 071881 | HERITAGE | 1988-04-05 | 19 |
| NDA 019614 | AZURITY | 1990-05-29 | 5 |
| ANDA 072924 | WATSON LABS | 1993-06-29 | 2 |
| ANDA 075136 | HOSPIRA | 1998-10-20 | 2 |
| NDA 020943 | AZURITY | 1998-11-25 | 4 |
| ANDA 075138 | MYLAN | 1999-04-20 | 5 |
| ANDA 078906 | GLENMARK PHARMS LTD | 2009-09-17 | 8 |
| ANDA 090700 | GLENMARK PHARMS LTD | 2011-08-03 | 9 |
| ANDA 206173 | CADILA PHARMS LTD | 2017-05-05 | 21 |
| ANDA 211035 | SOMERSET | 2018-06-18 | 1 |
| ANDA 211015 | SOMERSET THERAPS LLC | 2018-06-18 | 8 |
| ANDA 210994 | AMNEAL | 2018-07-13 | 2 |
| ANDA 211370 | MICRO LABS | 2018-12-28 | 6 |
| ANDA 213232 | CAPLIN | 2020-03-25 | 5 |
| ANDA 212965 | EUGIA PHARMA | 2020-07-06 | 4 |
| ANDA 214361 | GLAND | 2020-10-15 | 3 |
| ANDA 214215 | ZYDUS PHARMS | 2020-10-15 | 5 |
| ANDA 215829 | HERITAGE | 2022-03-17 | 2 |
| ANDA 214653 | MANKIND PHARMA | 2022-06-15 | 4 |
| ANDA 216471 | FRESENIUS KABI USA | 2024-04-23 | 1 |
| ANDA 219252 | ZYDUS LIFESCIENCES | 2025-11-24 | 6 |
Official labeling on DailyMed
- VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] · version 12 · 2026-08-24
- VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE) INJECTION [MICRO LABS LIMITED] · version 6 · 2026-08-20
- VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] · version 2 · 2026-07-24
- VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NIVAGEN PHARMACEUTICALS, INC.] · version 6 · 2026-07-20
- VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] · version 26 · 2026-07-15
- VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [LIFESTAR PHARMA LLC] · version 5 · 2026-07-13
- VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [SOMERSET THERAPEUTICS, LLC] · version 13 · 2026-07-06
- VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC.] · version 15 · 2026-06-30
- VERAPAMIL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [SAFECOR HEALTH LLC] · version 3 · 2026-06-30
- VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HENRY SCHEIN, INC.] · version 6 · 2026-06-23
- VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC.] · version 17 · 2026-06-03
- VERAPAMIL HYDROCHLORIDE TABLET [ZYDUS LIFESCIENCES LIMITED] · version 1 · 2026-05-21
Showing the 12 most recent of 96 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.